Emtricitabine (Tafero Em Tablets) About
Explore the stellar benefits of Tafero EM-the pharmaceutical-grade antiretroviral tablet featuring Emtricitabine (200 mg) and Tenofovir Alafenamide (25 mg). This superb oral medication offers a cost-effective, special rate solution for HIV-1 infection, in combination with other agents. Each white to off-white, film-coated, oval tablet is debossed with EM and supplied in secure HDPE bottles for extended shelf life up to 3 years. With an assay ranging from 98.0% to 102.0%, it delivers consistent, astounding performance and reliability. Manufactured in India, prescription only. Store below 30C in a dry, dark place.
Key Applications and Product Features
Tafero EM Tablets are uniquely suited for effective HIV-1 infection management in adults and adolescents. The film-coated design ensures patient compliance and stable delivery, while the robust combination of Emtricitabine and Tenofovir Alafenamide provides an advanced therapy option. The pharmaceutical-grade formulation boasts superb purity and efficacy, packaged securely for a shelf life of up to 36 months. Ideal for use in healthcare facilities, pharmacies, and as part of antiretroviral therapy regimens.
Main Domestic Market and Supply Details
Serving the expansive domestic market, Tafero EM Tablets are readily available throughout India. Samples can be handed over as per standard policy for healthcare professionals on request, allowing for clinical evaluation ahead of bulk supply. Quotations are provided upon inquiry, with flexible payment terms designed to streamline procurement. The packaging ensures 30 tablets per HDPE bottle, inside a protective carton, maintaining product integrity during transit and storage.
FAQ's of Emtricitabine (Tafero Em Tablets):
Q: How should Tafero EM Tablets be stored?
A: Tafero EM Tablets should be stored below 30C in a dry, dark environment to maintain efficacy and ensure product longevity throughout the 36-month shelf life.
Q: What is the primary indication for Tafero EM Tablets?
A: Tafero EM Tablets are indicated for the management of HIV-1 infection, used in combination with other antiretroviral agents to provide a comprehensive treatment regimen.
Q: When can healthcare professionals request samples of Tafero EM?
A: Healthcare professionals can request samples for evaluation as per the current sample policy. Samples will be handed over upon validation of credentials and compliance with medical guidelines.
Q: What makes Tafero EM Tablets a cost-effective choice for HIV-1 treatment?
A: Tafero EM Tablets combine two potent antiretroviral agents and are offered at special rates, providing stellar efficacy and superb patient adherence while minimizing overall treatment costs.
Q: Where are Tafero EM Tablets manufactured and supplied from?
A: Tafero EM Tablets are manufactured, supplied, and traded in India, with a focus on domestic distribution across healthcare facilities and pharmacies.